Login to Your Account



GSK Grabbing Sirtuin Platform With $720M Sirtris Acquisition

By Jennifer Boggs


Thursday, April 24, 2008
Sirtris Pharmaceuticals Inc. might not have been looking to be acquired, but GlaxoSmithKline plc came knocking with an offer too good to refuse, with a buyout bid of $22.50 per share, marking a total value of about $720 million. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription